deficiency

Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease DayEgetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

STOCKHOLM, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (Nasdaq Stockholm: EGTX), an innovative…

3 weeks ago
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting DeficiencySIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

Singapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider…

2 months ago
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting DeficiencySIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

Singapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider…

2 months ago
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting DeficiencySIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders Equity Deficiency and Annual Meeting Deficiency

Singapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider…

2 months ago
Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price RequirementsMolecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements

Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements

December 02, 2024 17:06 ET | Source: Molecular Templates, Inc. AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates,…

3 months ago
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-QIMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that…

4 months ago
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-QIMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that…

4 months ago
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-QIMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that…

4 months ago
AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) DeficiencyAlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency

AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency

Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infantsClinical estimates for SP-B deficiency…

4 months ago